Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, “Astellas”) and Seagen Inc. (Nasdaq: SGEN) …
Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031
Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to …
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC
Amgen (NASDAQ:AMGN) today announced exciting data from a study arm of the CodeBreaK 101 clinical …
Citius Pharmaceuticals to Participate in H.C. Wainwright and Sidoti Investor Conferences in September 2023
Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to …
First AI-Powered Precision Oncology Platform for Prostate Cancer Care, iQuestTM, Receives FDA Clearance
Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, today …
Wockhardt Hospitals, Mumbai Central in association with Specialty Surgical Oncology, Mumbai launches “Wockhardt Cancer Care Centre”
Wockhardt Hospitals, Mumbai Central in association with Specialty Surgical Oncology, Mumbai has launched Cancer Care …
Six start-ups in Oncology and Digital Health to receive grants of 65 lacs each under Pfizer’s INDovation Program
Program partners Pfizer Limited, Atal Innovation Mission (AIM), NITI Aayog, Social Alpha, Foundation for Innovation …
